Navigation Links
Colitis More Common in Hospitalized Patients

e 78,091,119 discharges that occurred in the 11-year study period, 299,453 patients had a diagnosis of C. difficile colitis, a rate of 383 cases per 100,000 discharged patients.

The rate of C. difficile colitis discharges increased from 261 cases per 100,000 discharged patients in 1993 to 546 cases per 100,000 discharged patients in 2003, a 109 percent increase, the authors write. Colectomy rate, which was 2.7 per 1,000 patients overall, increased from 1.2 per 1,000 patients in 1993 to 3.4 per 1,000 patients in 2003.

The total rate of death among patients with C. difficile colitis was 33.6 deaths per 100,000 discharged patients throughout the study; this rate increased 147 percent in 11 years, from 20.3 deaths per 100,000 discharged patients in 1993 to 50.2 deaths per 100,000 discharged patients in 2003.

Hospital discharge with a C. difficile diagnosis was significantly more likely with increasing calendar year, the authors continue. In addition, the likelihood of death and of treatment with colectomy also significantly increased over time.

The results document the changing nature of C. difficile colitis but do not offer explanations for the change, the authors note. The shift could be caused by new strains of the bacteria, its increasing resistance to antibiotics or the increasing severity of illness and therefore susceptibility to infection among hospitalized patients in the United States. Heightened awareness of the increasing disease burden of C. difficile colitis is an important first step in controlling the public health ramifications of this important and morbid nosocomial [hospital-acquired] infection, they conclude. (Arch Surg. 2007;142(7):624-631. Available pre-embargo to the media at www.jamamedia.org.) Editors Note: This study was supported by the University of Minnesota Academic Health Centers Clinical Scholars Research Grant. Please see the article for additional information, including other authors, author
'"/>




Page: 1 2 3 4

Related medicine news :

1. Bifidogenic Growth Stimulator: A Non-Toxic Way To Treat Ulcerative Colitis
2. Stubborn Ulcerative Colitis Responds to Arthritis Drug
3. Ulcerative Colitis Disrupts Many Aspects of Daily Life: Survey
4. Common contraception
5. Common Cold Remedy May Treat SARS
6. Common Plant Triggers Asthma
7. Pain Common in People with MS
8. Common Cold Found to Fight Cancer
9. Bullying – a Common Problem Among Childre
10. Common Medication Errors in Children
11. A Common Cause Of Allergy That Goes Unnoticed

Post Your Comments:
(Date:11/23/2009)...United States Department of Agriculture (USDA) has...ch and the University of Minnesota to complete seq...eagris gallopavo. The funding will be used by the ...e genome sequencing using next-generation sequenci...entify genes and functions in the final genome seq...
(Date:11/23/2009)... What could have been a simple case for a New Yo...s into a murder charge. , ...have been a case for New York auto accident attor...cident of road rage turned fatal., , , , ,Accordi...oklyn driver was shot and killed during a heated r...
(Date:11/23/2009)...PRNewswire-FirstCall/--AnnTaylorStoresCorp.announc...he6thannualThanksandGivingcampaign,aholidayfundrai...hHospital.ThisyearmarksthethirdyearthatAnnTaylor,t...ticipatedinthecampaignwhereweofferourshoppersanopp...dewhileshoppingthisholidayseason.ClientswhoshopatA...
(Date:11/23/2009)...n.,Nov.23/PRNewswire/--XiotechCorporationtodayanno...Emprise(TM)7000storagesystem,poweredbyIntelligentS...ntdatastorageneeds,enablefuturegrowthanddeliversig...itsdatacenter. ,, MasonGeneral,locatedinShelton...magazine,s"MostWired-Rural"hospitalsin2008and2009f...
(Date:11/23/2009)...23/PRNewswire/--Thanksgivingweekendmarksthe36thann...n,theClassicrepresentsthesportsmanshipandprideoftw...rleansandthoseinattendance. ,, Forthecrewofthen...somedowntimebeforetheyworktotestandlaunchabrandnew...ruction,PettyOfficerClaudeBovellandtherestofthecre...
Breaking Medicine News(10 mins):Health News:Turkey Genome Sequencing Consortium awarded $0.9 million from USDA 2Health News:An Incident of Road Rage Turns Into Murder 2Health News:Ann Taylor Stores Corp. Returns To St. Jude Children's Research Hospital's Thanks and Giving Campaign(R) For The Third Year 2Health News:ISE Technology by Xiotech Helps Hospital Achieve Data Center Efficiency, Savings 2Health News:Nothing Is Like Being There 2
...as State Approves Only,Program in The Bronx, NEW ...er disease and need a liver transplant will no lon...nd critically important follow-up,care outside the... a result of the New York State Department of Heal...
... been,part of Commonwealth Medical Group have anno...ce they provide to their patients by joining Auror... physicians, and we are delighted they,have decide...their care of patients in the Milwaukee area.", S...
...burning brown fat can be produced experimentally f...rospect of new ways to fight obesity and overweigh...e. , Reporting in the Aug. 21 issue of the journa...energy, unlike "bad" white fat that simply stores ...
...ators have found that infusions of a particular bo...stinal tissue from autoimmune attack in a mouse mo...em Cells , the team from the MGH Center for Engine...intestinal lining in mice with a genetic mutation ...
...Series, WASHINGTON, Aug. 20 America,s Agenda: He...ick" Gephardt, former U.S.,House majority leader, ...alth care for every American at the 2008 Democrati...nversations Series,on "American Health Care in the...
...ddler,spilled jam on your suit and now your car wo...Whether you brush it off and move on, or lash out ...t only yourself, but also,your spouse, your childr...t is important to,constructively express that ange...
Other Medicine News:Health News:Liver Transplant Program Established At Montefiore 2Health News:Liver Transplant Program Established At Montefiore 3Health News:Liver Transplant Program Established At Montefiore 4Health News:Commonwealth Medical Group Physicians to Join Aurora Health Care 2Health News:Making 'good' fat from muscle and vice versa 2Health News:Making 'good' fat from muscle and vice versa 3Health News:Bone marrow stem cells may help control inflammatory bowel disease 2Health News:Bone marrow stem cells may help control inflammatory bowel disease 3Health News:America's Agenda to Honor Former House Majority Leader Richard Gephardt at Democratic National Convention 2Health News:Taming Your Temper: Learning to Turn Down the Heat 2
(Date:11/23/2009)... THEWOODLANDS,Texas,Nov.23/PRNewswire-FirstCall/--...ncedtodaythattop-linedatafromitsPhase2clinicalstud...lebowelsyndrome(IBS)willbepresentedatGASTRO2009inL...ificantimprovementinIBSsymptoms,willbepresentedbyD...inicaldevelopment,onNovember25,2009at2:30pmlocalti...
(Date:11/23/2009)... FORTWORTH,Texas,Nov.23/PRNewswire-FirstCall/--Wou...DM)arapidlygrowingproviderofspecialtymedicalproduc...andhasprovidedacomprehensivemanagementbusinessupda...year. ,, Q32009salesincreased33.5%to$102,926vs...ftheQ32009increasedto$3,327,892vs.Q32008shareholde...
(Date:11/23/2009)... SOUTHSANFRANCISCO,Calif.,Nov.23/PRNewswire-FirstC...tDr.TedW.LoveandDr.DavidC.U,Prichardhaveagreedtojo...heproposedmergerbetweenAnesivaandArcionTherapeutic...scheduledtotakeplaceatthepreviouslyannouncedAnesiv...r3,2009at9:00a.m.PSTat400OysterPoint,Suite107A,Sou...
Breaking Medicine Technology:Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 3Firearm Owners and Seniors Coalesce Against Obama Agenda Says Gun Law Expert 55597 1Firearm Owners and Seniors Coalesce Against Obama Agenda Says Gun Law Expert 55597 2China Sky One Medical Inc to Hold Annual Meeting of Shareholders on September 24 2009 55595 1China Sky One Medical Inc to Hold Annual Meeting of Shareholders on September 24 2009 55595 2China Sky One Medical Inc to Hold Annual Meeting of Shareholders on September 24 2009 55595 3Avid Bioservices Expands Executive Team as it Prepares for Continued Growth 13728 1Avid Bioservices Expands Executive Team as it Prepares for Continued Growth 13728 2Avid Bioservices Expands Executive Team as it Prepares for Continued Growth 13728 3Avid Bioservices Expands Executive Team as it Prepares for Continued Growth 13728 4Avid Bioservices Expands Executive Team as it Prepares for Continued Growth 13728 5
...euticals, Inc. announced,today that it has closed ...ng. Aisling Capital led the round, with additional...ton Life Science Venture Corporation, and,current ...tures, BioFund,Ventures, HBM BioVentures, Lombard ...chnology Growth Capital. The second and final tran...
...Associated With Increased and Sustained Exposur...otecan, SAN FRANCISCO, Oct. 25 Nektar Therapeuti... data today on its proprietary,product candidate N...ernational Conference in San Francisco, California...ivity and unique pharmacokinetic profile of,NKTR-1...
Other Medicine Technology:Paratek Pharmaceuticals Announces the Close of $40 Million Private Placement to Finance Programs to Combat MRSA Infections 2Paratek Pharmaceuticals Announces the Close of $40 Million Private Placement to Finance Programs to Combat MRSA Infections 3Paratek Pharmaceuticals Announces the Close of $40 Million Private Placement to Finance Programs to Combat MRSA Infections 4NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models 2NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models 3NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models 4NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models 5
...tient Comfort than chest tubes and Enhanced Ambula...cone drains with four channels along the sides wit...ist of a silicone hub, a silicone extension tubing.../4 fluted (hub outside skin) or full fluted (hub i...
Laparoscopic Introducer Set
Fanelli Laparoscopic Endobiliary Stent Set
Common Duct Exploration Set: With N-Circle® Nitinol Tipless Stone Extractor
Medicine Products: